Serveur d'exploration sur l'Indium

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Trichlorido(5,5'-dimethyl-2,2'-bipyridine-κ(2) N,N')(dimethyl-formamide-κO)indium(III) hemihydrate.

Identifieur interne : 000964 ( Main/Exploration ); précédent : 000963; suivant : 000965

Trichlorido(5,5'-dimethyl-2,2'-bipyridine-κ(2) N,N')(dimethyl-formamide-κO)indium(III) hemihydrate.

Auteurs : RBID : pubmed:23468679

Abstract

The asymmetric unit of the title compound, [InCl3(C12H12N2)(C3H7NO)]·0.5H2O, contains two independent In(III) complex mol-ecules with similar structures and one lattice water mol-ecule. In each complex mol-ecule, the In(III) atom is six-coordinated in a distorted octa-hedral geometry, formed by two N atoms from the chelating 5,5'-dimethyl-2,2'-bipyridine ligand, one O atom from a dimethyl-formamide and three facial Cl atoms. In the crystal, the lattice water mol-ecule is linked to the complex mol-ecules via O-H⋯Cl hydrogen bonds. Further weak C-H⋯Cl and C-H⋯O hydrogen bonds result in the formation of a three-dimensional structure.

DOI: 10.1107/S1600536812044698
PubMed: 23468679

Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Trichlorido(5,5'-dimethyl-2,2'-bipyridine-κ(2) N,N')(dimethyl-formamide-κO)indium(III) hemihydrate.</title>
<author>
<name sortKey="Shirvan, Sadif A" uniqKey="Shirvan S">Sadif A Shirvan</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Chemistry, Omidieh Branch, Islamic Azad University, Omidieh, Iran.</nlm:affiliation>
<country xml:lang="fr">Iran</country>
<wicri:regionArea>Department of Chemistry, Omidieh Branch, Islamic Azad University, Omidieh</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Haydari Dezfuli, Sara" uniqKey="Haydari Dezfuli S">Sara Haydari Dezfuli</name>
</author>
<author>
<name sortKey="Khazali, Fereydoon" uniqKey="Khazali F">Fereydoon Khazali</name>
</author>
<author>
<name sortKey="Aghajeri, Manouchehr" uniqKey="Aghajeri M">Manouchehr Aghajeri</name>
</author>
<author>
<name sortKey="Borsalani, Ali" uniqKey="Borsalani A">Ali Borsalani</name>
</author>
</titleStmt>
<publicationStmt>
<date when="2012">2012</date>
<idno type="doi">10.1107/S1600536812044698</idno>
<idno type="RBID">pubmed:23468679</idno>
<idno type="pmid">23468679</idno>
<idno type="wicri:Area/Main/Corpus">000756</idno>
<idno type="wicri:Area/Main/Curation">000756</idno>
<idno type="wicri:Area/Main/Exploration">000964</idno>
</publicationStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The asymmetric unit of the title compound, [InCl3(C12H12N2)(C3H7NO)]·0.5H2O, contains two independent In(III) complex mol-ecules with similar structures and one lattice water mol-ecule. In each complex mol-ecule, the In(III) atom is six-coordinated in a distorted octa-hedral geometry, formed by two N atoms from the chelating 5,5'-dimethyl-2,2'-bipyridine ligand, one O atom from a dimethyl-formamide and three facial Cl atoms. In the crystal, the lattice water mol-ecule is linked to the complex mol-ecules via O-H⋯Cl hydrogen bonds. Further weak C-H⋯Cl and C-H⋯O hydrogen bonds result in the formation of a three-dimensional structure.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="PubMed-not-MEDLINE">
<PMID Version="1">23468679</PMID>
<DateCreated>
<Year>2013</Year>
<Month>03</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted>
<Year>2013</Year>
<Month>03</Month>
<Day>08</Day>
</DateCompleted>
<DateRevised>
<Year>2013</Year>
<Month>04</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1600-5368</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>68</Volume>
<Issue>Pt 12</Issue>
<PubDate>
<Year>2012</Year>
<Month>Dec</Month>
<Day>1</Day>
</PubDate>
</JournalIssue>
<Title>Acta crystallographica. Section E, Structure reports online</Title>
<ISOAbbreviation>Acta Crystallogr Sect E Struct Rep Online</ISOAbbreviation>
</Journal>
<ArticleTitle>Trichlorido(5,5'-dimethyl-2,2'-bipyridine-κ(2) N,N')(dimethyl-formamide-κO)indium(III) hemihydrate.</ArticleTitle>
<Pagination>
<MedlinePgn>m1448-9</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1107/S1600536812044698</ELocationID>
<Abstract>
<AbstractText>The asymmetric unit of the title compound, [InCl3(C12H12N2)(C3H7NO)]·0.5H2O, contains two independent In(III) complex mol-ecules with similar structures and one lattice water mol-ecule. In each complex mol-ecule, the In(III) atom is six-coordinated in a distorted octa-hedral geometry, formed by two N atoms from the chelating 5,5'-dimethyl-2,2'-bipyridine ligand, one O atom from a dimethyl-formamide and three facial Cl atoms. In the crystal, the lattice water mol-ecule is linked to the complex mol-ecules via O-H⋯Cl hydrogen bonds. Further weak C-H⋯Cl and C-H⋯O hydrogen bonds result in the formation of a three-dimensional structure.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Shirvan</LastName>
<ForeName>Sadif A</ForeName>
<Initials>SA</Initials>
<Affiliation>Department of Chemistry, Omidieh Branch, Islamic Azad University, Omidieh, Iran.</Affiliation>
</Author>
<Author ValidYN="Y">
<LastName>Haydari Dezfuli</LastName>
<ForeName>Sara</ForeName>
<Initials>S</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Khazali</LastName>
<ForeName>Fereydoon</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Aghajeri</LastName>
<ForeName>Manouchehr</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Borsalani</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType>Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2012</Year>
<Month>11</Month>
<Day>03</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Acta Crystallogr Sect E Struct Rep Online</MedlineTA>
<NlmUniqueID>101089178</NlmUniqueID>
<ISSNLinking>1600-5368</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22</RefSource>
<PMID Version="1">18156677</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr Sect E Struct Rep Online. 2008;64(Pt 9):m1211-2</RefSource>
<PMID Version="1">21201646</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr Sect E Struct Rep Online. 2012 Jun 1;68(Pt 6):m846</RefSource>
<PMID Version="1">22719383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr Sect E Struct Rep Online. 2008;64(Pt 11):m1353-4</RefSource>
<PMID Version="1">21580816</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Crystallogr Sect E Struct Rep Online. 2008;64(Pt 10):m1305</RefSource>
<PMID Version="1">21201044</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherID Source="NLM">PMC3588714</OtherID>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2012</Year>
<Month>10</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2012</Year>
<Month>10</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="epublish">
<Year>2012</Year>
<Month>11</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>3</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="doi">10.1107/S1600536812044698</ArticleId>
<ArticleId IdType="pii">xu5639</ArticleId>
<ArticleId IdType="pubmed">23468679</ArticleId>
<ArticleId IdType="pmc">PMC3588714</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000964 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000964 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23468679
   |texte=   Trichlorido(5,5'-dimethyl-2,2'-bipyridine-κ(2) N,N')(dimethyl-formamide-κO)indium(III) hemihydrate.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23468679" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a IndiumV2 

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024